ID29262A - Komposisi farmasi - Google Patents
Komposisi farmasiInfo
- Publication number
- ID29262A ID29262A IDW20002464A ID20002464A ID29262A ID 29262 A ID29262 A ID 29262A ID W20002464 A IDW20002464 A ID W20002464A ID 20002464 A ID20002464 A ID 20002464A ID 29262 A ID29262 A ID 29262A
- Authority
- ID
- Indonesia
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11727198 | 1998-04-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID29262A true ID29262A (id) | 2001-08-16 |
Family
ID=14707636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20002464A ID29262A (id) | 1998-04-27 | 1999-04-26 | Komposisi farmasi |
Country Status (24)
Country | Link |
---|---|
US (2) | US6673808B1 (id) |
EP (1) | EP1074255B1 (id) |
JP (1) | JP3732525B2 (id) |
KR (1) | KR100406823B1 (id) |
CN (1) | CN1161117C (id) |
AR (1) | AR018330A1 (id) |
AT (1) | ATE363275T1 (id) |
AU (1) | AU749475B2 (id) |
BR (1) | BR9910336A (id) |
CA (1) | CA2326222C (id) |
DE (1) | DE69936195T2 (id) |
ES (1) | ES2284248T3 (id) |
HK (1) | HK1038884B (id) |
HU (1) | HUP0104452A3 (id) |
ID (1) | ID29262A (id) |
IL (1) | IL139210A (id) |
NO (1) | NO20005399L (id) |
NZ (1) | NZ507345A (id) |
PL (1) | PL343627A1 (id) |
RU (1) | RU2203058C2 (id) |
TR (1) | TR200003108T2 (id) |
TW (1) | TW565461B (id) |
WO (1) | WO1999055332A1 (id) |
ZA (1) | ZA200005378B (id) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9826656D0 (en) | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
US7063857B1 (en) | 1999-04-30 | 2006-06-20 | Sucampo Ag | Use of macrolide compounds for the treatment of dry eye |
IL146162A0 (en) * | 1999-04-30 | 2002-07-25 | R Tech Ueno Ltd | Macrolide compounds for the treatment of dry eye |
SI2762140T1 (sl) * | 2001-02-19 | 2017-07-31 | Novartis Ag | Zdravljenje trdnih možganskih tumorjev z derivatom rapamicina |
GB0108498D0 (en) * | 2001-04-04 | 2001-05-23 | Novartis Ag | Organic Compounds |
AUPR529701A0 (en) * | 2001-05-28 | 2001-06-21 | Fujisawa Pharmaceutical Co., Ltd. | Pharmaceutical composition |
PE20030828A1 (es) * | 2002-03-04 | 2003-11-04 | Novartis Ag | Composicion oftalmica que comprende ascomicina |
GB0218996D0 (en) * | 2002-08-14 | 2002-09-25 | Novartis Ag | Organic compounds |
US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7083802B2 (en) * | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
US9211248B2 (en) | 2004-03-03 | 2015-12-15 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
CA3031270A1 (en) | 2004-03-03 | 2005-12-22 | Revance Therapeutics, Inc. | Compositions and methods for topical diagnostic and therapeutic transport |
WO2006001251A1 (ja) * | 2004-06-24 | 2006-01-05 | Kowa Co., Ltd. | アトルバスタチン外用剤組成物 |
EP1861112A4 (en) | 2005-03-03 | 2009-07-22 | Revance Therapeutics Inc | COMPOSITIONS AND METHODS FOR TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS |
CA2615990A1 (en) | 2005-07-18 | 2007-01-25 | Minu, L.L.C. | Enhanced ocular neuroprotection/neurostimulation |
FR2900052B1 (fr) * | 2006-04-19 | 2011-02-18 | Galderma Sa | Composition comprenant au moins une phase aqueuse et au moins une phase grasse comprenant de l'ivermectine |
CN101288643B (zh) * | 2008-06-17 | 2012-11-14 | 杨喜鸿 | 含有他克莫司的凝胶剂组合物及其制备方法和药物应用 |
EP2345414B1 (en) * | 2008-10-08 | 2014-06-25 | Takata Seiyaku Co., Ltd. | Tacrolimus preparation for external applications |
GB0917816D0 (en) | 2009-10-12 | 2009-11-25 | Biotica Tech Ltd | Novel compounds and methods for their production |
GB0917817D0 (en) | 2009-10-12 | 2009-11-25 | Biotica Tech Ltd | Novel compounds and methods for their production |
JP2011102260A (ja) * | 2009-11-11 | 2011-05-26 | Takada Seiyaku Kk | タクロリムス外用剤 |
JP5674786B2 (ja) * | 2010-07-23 | 2015-02-25 | マルホ株式会社 | タクロリムスを含有する水中油型クリーム状組成物 |
WO2012011192A1 (ja) * | 2010-07-23 | 2012-01-26 | マルホ株式会社 | タクロリムスを含有する水中油型クリーム状組成物 |
JP5652795B2 (ja) * | 2011-01-31 | 2015-01-14 | 国立大学法人大阪大学 | 皮膚疾患を処置するための外用薬およびその製造方法 |
CA3165081A1 (en) * | 2020-01-24 | 2021-07-29 | Toru Yasuzawa | External preparation containing rapamycin |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4454113A (en) * | 1982-09-21 | 1984-06-12 | Scm Corporation | Stabilization of oil and water emulsions using polyglycerol esters of fatty acids |
US5540931A (en) * | 1989-03-03 | 1996-07-30 | Charles W. Hewitt | Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants |
US4996193A (en) * | 1989-03-03 | 1991-02-26 | The Regents Of The University Of California | Combined topical and systemic method of administration of cyclosporine |
US4973468A (en) * | 1989-03-22 | 1990-11-27 | Cygnus Research Corporation | Skin permeation enhancer compositions |
DK0474126T3 (id) * | 1990-09-04 | 1997-04-07 | Fujisawa Pharmaceutical Co | |
TW213418B (id) * | 1991-05-02 | 1993-09-21 | Kuko Seiyaku Kk | |
JPH06128148A (ja) * | 1992-04-30 | 1994-05-10 | Dotsuto:Kk | 皮膚外用剤 |
JP2523428B2 (ja) * | 1992-12-04 | 1996-08-07 | エスエス製薬株式会社 | 消炎鎮痛ゲル製剤 |
JPH06345646A (ja) * | 1993-06-08 | 1994-12-20 | Fujisawa Pharmaceut Co Ltd | ローション剤 |
ATE214593T1 (de) * | 1994-10-26 | 2002-04-15 | Novartis Erfind Verwalt Gmbh | Verwendung eines ungesättigten fettalkohols |
WO1997024112A1 (fr) * | 1995-12-28 | 1997-07-10 | Yoshitomi Pharmaceutical Industries, Ltd. | Preparation a usage externe |
CZ267796A3 (cs) | 1996-09-12 | 1998-04-15 | Galena A.S. | Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů |
TW450810B (en) * | 1997-02-20 | 2001-08-21 | Fujisawa Pharmaceutical Co | Macrolides antibiotic pharmaceutical composition for preventing and treating skin diseases |
JP4221762B2 (ja) * | 1997-04-11 | 2009-02-12 | アステラス製薬株式会社 | 医薬組成物 |
-
1999
- 1999-04-26 AT AT99917179T patent/ATE363275T1/de not_active IP Right Cessation
- 1999-04-26 ID IDW20002464A patent/ID29262A/id unknown
- 1999-04-26 AU AU35372/99A patent/AU749475B2/en not_active Ceased
- 1999-04-26 PL PL99343627A patent/PL343627A1/xx not_active Application Discontinuation
- 1999-04-26 TR TR2000/03108T patent/TR200003108T2/xx unknown
- 1999-04-26 WO PCT/JP1999/002237 patent/WO1999055332A1/ja active IP Right Grant
- 1999-04-26 NZ NZ507345A patent/NZ507345A/xx unknown
- 1999-04-26 KR KR10-2000-7011259A patent/KR100406823B1/ko not_active IP Right Cessation
- 1999-04-26 EP EP99917179A patent/EP1074255B1/en not_active Expired - Lifetime
- 1999-04-26 ES ES99917179T patent/ES2284248T3/es not_active Expired - Lifetime
- 1999-04-26 CN CNB998079367A patent/CN1161117C/zh not_active Expired - Fee Related
- 1999-04-26 CA CA002326222A patent/CA2326222C/en not_active Expired - Fee Related
- 1999-04-26 RU RU2000129665/14A patent/RU2203058C2/ru not_active IP Right Cessation
- 1999-04-26 DE DE69936195T patent/DE69936195T2/de not_active Expired - Lifetime
- 1999-04-26 BR BR9910336-2A patent/BR9910336A/pt not_active IP Right Cessation
- 1999-04-26 JP JP54808699A patent/JP3732525B2/ja not_active Expired - Fee Related
- 1999-04-26 AR ARP990101921A patent/AR018330A1/es unknown
- 1999-04-26 US US09/673,260 patent/US6673808B1/en not_active Expired - Fee Related
- 1999-04-26 HU HU0104452A patent/HUP0104452A3/hu unknown
- 1999-04-26 IL IL13921099A patent/IL139210A/xx not_active IP Right Cessation
- 1999-04-27 TW TW088106893A patent/TW565461B/zh active
-
2000
- 2000-10-03 ZA ZA200005378A patent/ZA200005378B/en unknown
- 2000-10-26 NO NO20005399A patent/NO20005399L/no not_active Application Discontinuation
-
2001
- 2001-12-07 US US10/005,645 patent/US6586444B2/en not_active Expired - Fee Related
-
2002
- 2002-01-22 HK HK02100502.9A patent/HK1038884B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID27415A (id) | Komposisi farmaseutik | |
NO20005913D0 (no) | Legemiddelsammensetning | |
EA199900373A3 (ru) | Фармацевтические композиции | |
NO20015175L (no) | Farmasöytisk sammensetning | |
ID22891A (id) | Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan | |
ID29262A (id) | Komposisi farmasi | |
FI991485A0 (fi) | Uusi farmaseuttinen koostumus | |
ID29089A (id) | Sediaan farmasi moksifloksasin | |
DK1466615T3 (da) | Farmaceutisk præparat | |
DE69942892D1 (de) | Gaserzeugende zusammensetzung | |
DE69928862D1 (de) | Zusammensetzung | |
ID27201A (id) | Komposisi farmasi | |
ID27150A (id) | Sediaan levotiroksin bahan farmasi | |
ID29294A (id) | Komposisi farmasi | |
ID30032A (id) | Formulasi farmasi | |
ID25857A (id) | Komposisi farmasi | |
FI4488U1 (fi) | Farmaseuttinen koostumus | |
PT1227817E (pt) | Composicao farmaceutica aquosa contendo ciclesonida | |
ID18698A (id) | Komposisi farmasi | |
EE200100281A (et) | Analgeetiline ravimkoostis | |
ID26215A (id) | Komposisi farmasi | |
ITMI962628A0 (it) | Composizione farmaceutica | |
DE69939964D1 (de) | Gelförmige Zusammensetzung | |
ID23531A (id) | Komposisi farmasi | |
FI981567A0 (fi) | Farmaseuttiset koostumukset |